Predicting Remission and Low Disease Activity Attainment in Patients with Systemic Lupus Erythematosus

被引：0
|
作者：
Da Mutten, Raffaele [1 ,2 ]
Cetrez, Nursen [1 ]
Lindblom, Julius [1 ]
Oon, Shereen [3 ]
Nikolopoulos, Dionysis [1 ,2 ]
Nikpour, Mandana [4 ,5 ]
Parodis, Ioannis [1 ,2 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Div Rheumatol, Dept Med Solna, Stockholm, Sweden
[3] St Vincents Hosp, Fitzroy, Vic, Australia
[4] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Melbourne, Vic, Australia
[5] Univ Melbourne, St Vincents Hosp Melbourne, Dept Rheumatol, Melbourne, Vic, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2320
引用
下载
收藏
页码：4596 / 4597
页数：2
相关论文
共 50 条
  • [31] Low Disease Activity in Systemic Lupus Erythematosus: An Achievable Goal?
    Tani, Chiara
    Vagelli, Roberta
    Stagnaro, Chiara
    Carli, Linda
    Signorini, Viola
    Mosca, Marta
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Toward the Definition of Low Disease Activity in Systemic Lupus Erythematosus
    Polachek, Ari
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1186 - 1187
  • [33] Low Disease Activity Early in the Course of Systemic Lupus Erythematosus
    Ugarte-Gil, Manuel F.
    Alarcon, Graciela S.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 739 - 740
  • [34] The Impact of Remission and Low Disease Activity Attainment on Health-related Quality of Life in Two Phase III Clinical Trials of Belimumab in Systemic Lupus Erythematosus
    Emamikia, Sharzad
    Oon, Shereen
    Gomez, Alvaro
    Lindblom, Julius
    Borg, Alexander
    Enman, Yvonne
    Morand, Eric
    Grannas, David
    van Vollenhoven, Ronald
    Nikpour, Mandana
    Parodis, Ioannis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2604 - 2606
  • [35] Predicting the effect of sirolimus on disease activity in patients with systemic lupus erythematosus using machine learning
    Wang, Dong-Dong
    Li, Ya-Feng
    Zhang, Cun
    He, Su-Mei
    Chen, Xiao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (11) : 1845 - 1850
  • [36] Prolonged Clinical Remission in Patients with Systemic Lupus Erythematosus
    Steiman, Amanda J.
    Urowitz, Murray B.
    Ibanez, Dominique
    Papneja, Anjali
    Gladman, Dafna D.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (09) : 1808 - 1816
  • [37] The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission
    Zen, Margherita
    Gatto, Mariele
    Nalotto, Linda
    Larosa, Maddalena
    Laccarino, Luca
    Doria, Andrea
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (07): : 454 - 458
  • [38] Complement Activation in Systemic Lupus Erythematosus Patients with Low Disease Activity Is Not Inhibited by Hydroxychloroquine
    Troldborg, Anne Margrethe
    Hansen, Annette
    Stengaard-Pedersen, Kristian
    Thiel, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] PROLONGED CLINICAL REMISSION AND LOW DISEASE ACTIVITY STATUSES ARE ASSOCIATED WITH BETTER QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Poomsalood, Nareerat
    Chaiamnuay, Sumapa
    Narongroeknawin, Pongthorn
    Asavatanabodee, Paijit
    Pakchotanon, Rattapol
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1703 - 1704
  • [40] Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus
    Poomsalood, N.
    Narongroeknawin, P.
    Chaiamnuay, S.
    Asavatanabodee, P.
    Pakchotanon, R.
    LUPUS, 2019, 28 (10) : 1189 - 1196
12345